🇺🇸 FDA
Patent

US 9044391

Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

granted A61KA61K31/436A61K38/13

Quick answer

US patent 9044391 (Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery) held by The Board of Regents of the University of Texas System expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/436, A61K38/13, A61K9/0075, A61K9/0078